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CASE REPORT
A 78-year-old man with a diagnosis of a 3.6-cm AAA 3 years
earlier was noted to have an enlarging aneurysm of 4.8 cm on a
surveillance ultrasound scan that was confirmed by computed
tomography (CT). Because of a family history of aortic
aneurysm rupture and evidence of aneurysm enlargement, the
patient was evaluated for an endovascular AAA repair and was
deemed a suitable candidate for aortic endograft placement. He
underwent an uneventful endovascular grafting using a modular
bifurcated stent-graft device (Excluder, W. L. Gore and
Associates, Inc, Flagstaff, Ariz) in June 1999. No endoleak was
identified on completion angiography or spiral CT at the time of
discharge. However, the 1-month, 6-month, and 12-month fol-
low-up CT scans demonstrated contrast extravasation into the
AAA sac with no increase in aneurysm diameter (Fig 1). Because
of the persistent endoleaks, the patient underwent a diagnostic
and therapeutic aortogram in an effort to identify and eliminate
the endoleak 13 months after the endovascular stent-grafting
procedure. Via a right femoral artery access, the patient’s supe-
rior mesenteric artery (SMA) was cannulated using a 0.035-in
Bentson guidewire (Boston Scientific Vascular/Medi-tech,
Oakland, NJ) and a Barenstein catheter (Medi-tech). Next a
coaxial microcatheter (Fast Tracker, Boston Scientific Vascular,
Natick, Mass) was used to gain access to the aneurysm sac from
the SMA through the IMA by means of the marginal artery. A
combination of thrombin solution (2000 units; Gentrac,
Middletown, Wis), lipiodol (2 mL; Therapex, Montreal,
Quebec), Gelfoam powder (1 g, Pharmacia & Upjohn Co,
Kalamazoo, Mich) was introduced into the sac via the micro-
catheter (Fig 2). The catheter system was then withdrawn into
the origin of the IMA for embolization. Although completion
angiography demonstrated no flow into either the aneurysm sac
or the IMA, the sigmoidal arteries were noted to be thrombosed
(Fig 3).
The goal of endovascular abdominal aortic aneurysm
(AAA) repair is to prevent aneurysm rupture by means of
excluding the aneurysm from the aortic circulation using
the stent-graft device. Several reports noted that 8% to
44% of patients have a persistent flow within the aortic
aneurysm sac, also known as an endoleak, despite a tech-
nically successful endovascular AAA repair.1-3 The pres-
ence of an endoleak implies potential pressurization of the
AAA, which, if left untreated, may lead to aneurysm
enlargement and subsequent rupture. A type II endoleak
is characterized by the persistent flow of side-branch ves-
sels that perfuse the aneurysm sac, with the inferior
mesenteric artery (IMA) and lumbar arteries being the
most common side-branch vessels.1,2,4 We herein report a
patient with a type II endoleak 1 year after endovascular
AAA repair who underwent a transcatheter embolization
of the aneurysm sac and the IMA in an effort to eliminate
the endoleak, which resulted in colonic necrosis. The pos-
sible causes of such a complication as well as lessons we
learned from this experience are discussed in this report.
1119
From the Joseph B. Whitehead Department of Surgery, Division of
Vascular Surgery, and the Department of Radiology, Emory University
School of Medicine and the Emory University Hospital.
Competition of interest: nil.
Reprint requests: Peter H. Lin, MD, The Emory Clinic, 1365A Clifton Rd,
NE, Suite 3323, Atlanta, GA 30322 (e-mail: peter_lin@emory.org).
Published online Nov 1, 2001.
Copyright © 2001 by The Society for Vascular Surgery and The American
Association for Vascular Surgery.
0741-5214/2001/$35.00 + 0 24/4/118824
doi:10.1067/mva.2001.118824
CASE REPORTS
Colonic necrosis subsequent to catheter-directed
thrombin embolization of the inferior mesenteric
artery via the superior mesenteric artery: A
complication in the management of a type II
endoleak
Ruth L. Bush, MD, Peter H. Lin, MD, Russell S. Ronson, MD, Brian S. Conklin, BS, Louis G. Martin,
MD, and Alan B. Lumsden, MD, Atlanta, Ga
The optimal management of endoleaks after endovascular repair of abdominal aortic aneurysms remains to be estab-
lished. In this report, we describe a persistent side-branch, or type II, endoleak 1 year after endograft implantation
treated with catheter-directed embolization of the aneurysm sac and the inferior mesenteric artery via the superior
mesenteric artery, with embolization agents including thrombin, lipiodol, and Gelfoam powder. Shortly after the
embolization procedure, colonic necrosis developed in the patient, manifested by peritonitis, which necessitated a par-
tial colectomy. This case underscores the devastating complication of colonic ischemia as a result of catheter-directed
embolization of the inferior mesenteric artery in the management of an endoleak. (J Vasc Surg 2001;34:1119-22.)
Six hours after the procedure, back pain and mild lower
abdominal pain developed in the patient. The abdominal pain
progressed to severe guarding with mild rebound tenderness. The
patient developed a fever of 102.2°F and a leukocytosis of
30,000. Diagnostic laparoscopy revealed a necrotic sigmoid colon
and was followed by an exploratory laparotomy and a left hemi-
colectomy and transverse colostomy placement. The patient
recovered without further incident and was discharged to a reha-
bilitation center on postoperative day 15. Abdominal CT scan-
ning 3 months later showed no evidence of an endoleak, and the
aneurysm diameter remained unchanged.
DISCUSSION
Incomplete exclusion of an AAA after implantation of
an endovascular graft has been reported to occur in 8% to
44% of all cases, which poses a potential threat of contin-
uous aneurysm expansion and thus constitutes a failure of
endoluminal repair.1-3 The optimal timing of intervention
and the methodology of the treatment of an endoleak
remain challenging and often controversial issues.
Concern is for continued pressurization of the aneurysmal
sac with subsequent rupture. Retrograde flow via branch
vessels such as the IMA or lumbar arteries is responsible
for the majority of type II endoleaks, requiring the elimi-
nation of flow to protect the aneurysm from possible
enlargement.4-6 There is a general consensus that persis-
tent endoleaks leading to aneurysm expansion necessitate
treatment by either operative or endovascular interven-
tion.6-8 However, in the presence of a type II endoleak
without aneurysm expansion, the timing and indication
for intervention remain controversial.6-8
Despite the lack of a demonstrable aortic aneurysm
enlargement in our patient, his persistent endoleak 1 year
after the endograft placement prompted us to intervene.
Because the CT of the abdomen showed a persistent flow
in the IMA and the intraoperative angiogram confirmed
the absence of either proximal or distal attachment
endoleak, we were certain that a type II endoleak was pre-
sent in our patient. It is noteworthy that a type II endoleak
implies the presence of at least two side branch vessels that
provide a continuous flow circuitry within the aneurysm
sac. Because the aortogram only identified a patent IMA in
our patient, we postulated that a second side branch vessel
was present but not visible by currently available diagnos-
tic imaging modalities. We therefore chose to perform a
catheter-directed embolization of both the IMA orifice and
the aneurysm sac via the SMA using liquid embolic mate-
rials that included lipiodol, thrombin, and Gelfoam. We
hypothesized that by administering these liquid agents in
the aneurysm sac and IMA orifice, the diffuse permeation
of these materials could effectively induce thrombosis
within the aneurysm sac along with any remaining patent
side branches. In contrast to catheter-directed coil place-
ment, the liquid property of these embolic materials pro-
vided a theoretical advantage that more diffuse aneurysm
sac thrombosis could be achieved without packing a large
amount of coils in the aneurysm sac.
The Gelfoam and thrombin were used as embolic
agents because of their prothrombotic properties.
Lipiodol was also chosen because it is a highly visible oil
that facilitated the visualization of the embolization
process. The inclusion of lipiodol raises a potential con-
cern because of its radioopacity, which may interfere with
future endoleak detection. This issue is overcome by the
availability of new CT computer software (ImageWare,
Inc, Atlanta, Ga) that permits subtraction of a pre-existing
contrast-enhanced density on a CT scan (such as lipiodol),
thus allowing future detection of a new contrast-enhanced
JOURNAL OF VASCULAR SURGERY
1120 Bush et al December 2001
Fig 1. Abdominal CT scan demonstrating an endoleak (arrow)
after the stent-graft placement.
Fig 2. A microcatheter was used to cannulate the SMA, traverse
the IMA via the middle colic artery, and finally reach the
aneurysm sac for thrombin and Gelfoam embolization.
density (such as a new endoleak). The mixture of Gelfoam,
thrombin, and lipiodol resulted in a liquid embolization
fluid that became rather unpredictable in its ability to
remain localized within the aneurysm sac or the IMA ori-
fice after catheter-directed infusion. These agents were
extruded by hand injection through a syringe into the
aneurysm sac via the subselective catheterization of the
IMA via the SMA. After that, the catheter system was
slowly withdrawn, and IMA origin was embolized using
the liquid embolic materials. The manipulation of the
catheter containing embolization agents at this point
raised several concerns. First, particles or fragments that
initiate thrombosis by forming a gelatinous mass may
lodge in and occlude the catheterized artery and its larger
branches. During catheter removal, minute fragments may
potentially remain in the collateral arcades between the
SMA and IMA, leaving these important collaterals inad-
vertently thrombosed by the trailing embolization mater-
ial. Indeed, the completion angiogram demonstrated
occluded sigmoidal artery branches, presumably a result of
inadvertent migration and embolization of the embolic
agents, which undoubtedly contributed to our patient’s
colonic necrosis.
The use of catheter-directed infusion of gelatin sponge
fragments, thrombin, or polyvinyl alcohol has been
described previously in the management of gastrointesti-
nal hemorrhage.9,10 A major disadvantage of particulate
materials is bowel infarction from distal migration, espe-
cially with very small particles.11 Even though tran-
scatheter embolization has been reported to be a definitive
and effective means of treating patients with lower gas-
trointestinal hemorrhage, intestinal ischemia and infarc-
tion have occurred in as many as 20% of cases, limiting this
procedure to being recommended for high-risk patients
who are not deemed candidates for emergency surgery.9,10
In retrospect, the application of thrombin and Gelfoam in
the IMA in our patient was a hazardous maneuver, given
the high incidence of bowel infarction derived from the
gastrointestinal hemorrhage literature.
Recent literature has demonstrated the safety and effi-
cacy of coil embolization of the perigraft space and out-
flow vessels.3,5,12,13 With this treatment option, tight coil
packing of endoleaks is thought to be important in achiev-
ing solid thrombus formation and preventing further flow
into the aneurysm sac. Furthermore, oversizing the coil
should lessen the likelihood of migration once it is
deployed within a vessel or the aneurysm sac, which could
have avoided the inadvertent sigmoidal artery occlusion
seen in our patient. Whereas it is probable that catheter-
directed coil placement in the aneurysm sac and the IMA
in our patient could have avoided the devastating compli-
cation of colonic necrosis, this option was not chosen in
our patients because of several reasons. First, it would
require an enormous number of coils to fully pack the
aneurysm sac to achieve a complete aneurysm sac throm-
bosis. Second, catheter manipulation via the mesenteric
vessel for coil placement within the aneurysm sac would be
technically challenging to ensure that coils are adequately
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placed throughout the aneurysm sac. And last, placement
of a large number of coils may render subsequent endoleak
evaluation difficult because of coil-related artifacts on
future CT of the abdomen.
An alternative treatment for type II endoleaks is that
of retroperitoneal endoscopic ligation of the IMA and the
lumbar arteries.14 In addition, percutaneous translumbar
embolization of the aneurysm sac or placement of throm-
bogenic sponges in the aneurysm sac have been reported
to be feasible in anecdotal reports.15,16 Unknown, how-
ever, is the appropriate timing of a secondary endovascu-
lar intervention, because a significant percentage of type II
leaks will seal spontaneously after stent-graft implantation.
The length of time that an endoleak may be safely
observed has not been determined and may depend on the
degree of aneurysm expansion. Given the relative stable
aneurysm diameter of 4.8 cm in our patient despite the
persistent type II endoleak, continuous surveillance may
remain a viable alternative. Under such a circumstance,
intervention of the endoleak should be considered when
the aneurysm displays evidence of enlargement.
In summary, we described a case of persistent type II
endoleak 1 year after endovascular AAA repair. With selective
IMA catheterization via the SMA, various embolization
agents including thrombin and Gelfoam were infused into
the aneurysm sac and IMA orifice. With the resultant colonic
necrosis caused by inadvertent sigmoidal artery emboliza-
tion, the intervention performed in our patient was clearly
hazardous and undoubtedly contributed to his catastrophic
complication. We strongly recommend that such a maneuver
be avoided in the management of a type II endoleak.
Fig 3. After embolization of the aneurysm sac and the IMA ori-
fice, the completion angiogram demonstrates radio-opaque lipi-
odol mixture in the aneurysm sac with occluded sigmoidal artery
branches (arrows).
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